ACET — ADICET BIO INC

Ownership history in Prosight Management, LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Prosight Management, LP reported a position in ADICET BIO INC (ACET). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.44% (2025 Q4)
Avg. % of fund
0.44%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 250,244 — — 0.44% $2.1M $8.42
% of Fund (quarterly)    ACET price (monthly, adj. close)

Other funds also holding ACET

As of 2025 Q4 — sorted by position size

REGENERON PHARMACEUTICALS, INC. 1.51% Stonepine Capital Management, LLC 3Y 7Y 1.35% LUMINUS MANAGEMENT LLC 3Y 7Y 0.44% DAFNA Capital Management LLC 3Y 7Y 0.18% ORBIMED ADVISORS LLC 3Y 7Y 0.18% Rangeley Capital, LLC 0.17% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.08% ADAR1 Capital Management, LLC 0.08% Burkehill Global Management, LP 0.03% JOHNSON & JOHNSON 3Y 0.03%
← Back to Prosight Management, LP Holdings